Onkure Therapeutics, Inc. · NASDAQ:OKUR
ADAR1 Capital Management, LLC's stake in Onkure Therapeutics, Inc. fell to 5.50% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
ADAR1 Capital Management, LLC's stake in Onkure Therapeutics, Inc. fell to 5.50%, 2,238,684 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 2,238,684
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ADAR1 Capital Management, LLC | 5.50% | 2,238,684 |
| ADAR1 Capital Management GP, LLC | 4.50% | 1,832,117 |
| Daniel Schneeberger | 5.50% | 2,238,684 |
Source
Related
- Onkure Therapeutics, Inc.
- ADAR1 Capital Management, LLC
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G/A · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Feb 17, 2026
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G/A · Prosight Management, LP · Aug 10, 2026